Rankings
▼
Calendar
STAA
STAAR Surgical Company
$871M
Q3 2019 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$39M
+22.9% YoY
Gross Profit
$29M
74.4% margin
Operating Income
$3M
8.5% margin
Net Income
$2M
6.1% margin
EPS (Diluted)
$0.05
QoQ Revenue Growth
-1.5%
Cash Flow
Operating Cash Flow
$12M
Free Cash Flow
$9M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$193M
Total Liabilities
$43M
Stockholders' Equity
$149M
Cash & Equivalents
$112M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$39M
$32M
+22.9%
Gross Profit
$29M
$24M
+21.8%
Operating Income
$3M
$2M
+110.6%
Net Income
$2M
$1M
+63.7%
Revenue Segments
Implantable Collamer Lenses
$34M
87%
Intraocular Lenses
$4M
10%
Other Surgical Products
$1M
3%
Geographic Segments
CHINA
$18M
47%
Other Countries
$13M
34%
JAPAN
$7M
19%
← FY 2019
All Quarters
Q4 2019 →
STAA Q3 2019 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena